(Q33393655)

English

Feasibility, toxicity, and efficacy of short induction chemotherapy of docetaxel plus cisplatin or carboplatin (TP) followed by concurrent chemoradio-therapy for organ preservation in advanced cancer of the hypopharynx, larynx, and base of tongue. E

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Feasibility, toxicity, and efficacy of short induction chemotherapy of docetaxel plus cisplatin or carboplatin (TP) followed by concurrent chemoradio-therapy for organ preservation in advanced cancer of the hypopharynx, larynx, and base of tongue. E (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

9

object named as

Rainer Fietkau

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

author name string

Sabine Semrau

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Frank Waldfahrer

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Michael Lell

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Rainer Linke

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Gunther Klautke

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Torsten Kuwert

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Michael Uder

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Heinrich Iro

8

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

publication date

22 December 2010

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Strahlentherapie und Onkologie

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

187

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

15-22

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Phase II study of tolerance and efficacy of hyperfractionated radiotherapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in stage III and IV inoperable and/or unresectable head-and-neck squamous cell carcinoma: A-2 protocol

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2178-2

21 January 2018

Reirradiation with alternating docetaxel-based chemotherapy for recurrent head and neck squamous cell carcinoma: update of a single-center prospective phase II protocol

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2178-2

21 January 2018

Dysphagia after chemoradiotherapy for head-and-neck squamous cell carcinoma: dose-effect relationships for the swallowing structures

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2178-2

21 January 2018

Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2178-2

21 January 2018

Combined radiochemotherapy with docetaxel in patients with unresectable locally advanced head and neck tumors

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2178-2

21 January 2018

Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2178-2

21 January 2018

Phase II trial of a simultaneous radiochemotherapy with cisplatinum and paclitaxel in combination with hyperfractionated-accelerated radiotherapy in locally advanced head and neck tumors.

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2178-2

21 January 2018

Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2178-2

21 January 2018

Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: a dose-effect relationship.

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2178-2

21 January 2018

Adjusting for patient selection suggests the addition of docetaxel to 5-fluorouracil-cisplatin induction therapy may offer survival benefit in squamous cell cancer of the head and neck

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2178-2

21 January 2018

Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2178-2

21 January 2018

Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2178-2

21 January 2018

Sequential therapy for the locally advanced larynx and hypopharynx cancer subgroup in TAX 324: survival, surgery, and organ preservation

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2178-2

21 January 2018

Radiochemotherapy including cisplatin alone versus cisplatin + 5-fluorouracil for locally advanced unresectable stage IV squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2178-2

21 January 2018

Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2178-2

21 January 2018

Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2178-2

21 January 2018

Organ function and quality of life after transoral laser microsurgery and adjuvant radiotherapy for locally advanced laryngeal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21234526

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemoradiotherapy with weekly cisplatin 40 mg/m(2) in 103 head-and-neck cancer patients: a cumulative dose-effect analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21234526

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aggressive Simultaneous Radiochemotherapy with Cisplatin and Paclitaxel in Combination with Accelerated Hyperfractionated Radiotherapy in Locally Advanced Head and Neck Tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/21234526

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21234526

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Docetaxel, cisplatin, and fluorouracil induction chemotherapy followed by accelerated fractionation/concomitant boost radiation and concurrent cisplatin in patients with advanced squamous cell head and neck cancer: A Southwest Oncology Group [...]

1 reference

https://pubmed.ncbi.nlm.nih.gov/21234526

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00066-010-2178-2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33393655&oldid=2195317539"